Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.
As noted in a recent article published in Inside Precision Medicine, in 1992 gene therapy was often discussed but seldom practiced. When Jim Wilson MD, PhD attended Penn State, gene…
Continue Reading
Jim Wilson’s Pioneering Journey: Transforming Rare Disease Treatment Through Innovative Gene Therapy Part 1
Xspray Pharma, the developer of the drug dasatinib, was recently issued a Complete Response Letter (CRL) by the FDA while waiting for corrective actions, according to Cancer Network. Based on…
Continue Reading
The FDA has Issued a Complete Response Letter to Xspray Pharma Delaying Approvals Affecting ALL and CML
According to a press release from Syndax Pharmaceuticals, the developer of Revumenib, the drug met its primary endpoint resulting in complete remission (CR) or CR with partial recovery. Relapsed or…
Continue Reading
Syndax Pharmaceutical’s Revumenib Meets its Primary Endpoint to Treat Relaxed/Refractory Acute AML
A recently published study in The Lancet reports that over 54,600 children living in Gaza are severely malnourished. In addition, as of August 2025, there are few therapeutic options available…
Continue Reading
New Lancet Study Highlights Severe Malnutrition in Gaza
Over 9,300 individuals living in the United States are currently waiting for a liver transplant. There is a serious need for liver donors. This message was recently sent out by…
Continue Reading
Urgent Message from the American Liver Foundation
Immuneering’s midstage pancreatic deep cyclic MEK protein inhibitor, (DCI), almost doubled the standard overall survival. It is a deep cycle inhibitor that targets key pathways in a pulsed manner. Results…
Continue Reading
Overall Survival Nearly Doubles in Immuneering’s Midstage Pancreatic Cancer Trial
A recent study by UCLA researchers of in-home murders of children twelve and under revealed that according to the National Violent Death Reporting System and other agencies, nearly one quarter…
Continue Reading
In-Home Homicides of Young Children In their Own Home More than Doubled from 2001 to 2020
Medetoidine is an animal sedative increasingly being found in human opioid deaths according to published reports in the journal “The Conversation” and shared on MedicalXpress. Synthetic opioids claim thousands of lives…
Continue Reading
Animal Sedatives Found in Opioid Deaths
In a recent study, deficiency in Vitamin D was associated with an elevated risk of developing Alzheimer’s disease. Yet there were no indications that it is the direct cause of…
Continue Reading
Does Vitamin D Deficiency Have an Impact on Alzheimer’s Disease?
After the death of six patients, the FDA has announced that it will require earlier and more frequent monitoring of the monoclonal antibody Leqembi, the brand name for the Alzheimer’s…
Continue Reading
The FDA Now Requires Increased MRI Monitoring for Alzheimer’s Patients Who Are Treated with Leqembi
Researchers at UC Berkeley, DTU, and OptoCeutics in Denmark have created a non-medical light-based technology that improved cognitive function for Alzheimer’s patients who have participated in previous clinical trials. The…
Continue Reading
Denmark Researchers Have Created a Light-Based Technology That Improves Cognitive Function for Alzheimer’s Patients
A new study recently published in the European journal of Preventive Cardiology and reported by Medical News Today, noted that individuals who added extra steps plus reasonable speed to their…
Continue Reading
Reducing the Risk of Heart Attacks and Strokes with a Few Steps a Day
Studies by highly accredited Mayo Clinic and Barrow Neurological researchers report finding an association between living in close proximity to a golf course and an increased risk of Parkinson’s disease…
Continue Reading
Living Near a Golf Course: A Golfer’s Dream (Or So We Thought)
Shebli Atrash, MD, Levine Cancer Institute medical oncologist and associate professor of medicine at the University of Wake Forest interviewed with Medical Express following his presentation at the 2025 Conference in…
Continue Reading
Immune Therapies will have significant Role in the Future of Oncology Treatment
Lancet Oncology Recently published reports updating the findings from the phase 3 DREAMM 7 trial involving 494 patients averaging ages 64.5 years with the median follow-up of 39.4 months. Accordingly, patients…
Continue Reading
Updating the findings from Phase 3 DREAMM 7 trials for Relapsed/refractory Multiple Myeloma Patients
Novel radioactive medicine may be an inconvenient read for many people, but if you or someone you care about has metastatic breast cancer the words will soon become part of…
Continue Reading
Novel Radioactive Medicine used to Treat First US Breast Cancer Patient
How do you prioritize your responsibility as a caregiver when there is illness in the family? Especially when your husband is facing new rounds of chemotherapy and a fourteen-year-old autistic…
Continue Reading
A Review of “Last Nerve” by Mindy Uhrlaub
Editor's Note: This story is a continuation of Jenny Decker's global sailing voyage. To see the original article, please click here. Many of our Patient Worthy readers are aware that…
Continue Reading
Jenny Decker’s Journey: Just a Lap
Here's a more detailed explanation. The newest American Cancer Society study just released suggests that a diagnosis of cancer is no longer a death sentence. According to a recent U.S.…
Continue Reading
And the Good News is . . .Cancer Survivors in the United States are Projected to Exceed 22 million people by 2035
The study, published in the journal The Lancet Neurology and reported by MedicalXpress.com, is the first to demonstrate the urgency of extending imaging that includes the heart. This must be accomplished within…
Continue Reading
New Study: Extending Imaging Including the Heart Upon Arrival in E.R. Helps Determine Cause of a Stroke
One death is too many - Especially when it can be prevented. The new MGB policy will benefit patients who are at risk of deadly toxicities from a widely prescribed…
Continue Reading
Mass General (MGB) Has Adopted Pretreatment DPYD Testing for Patients at risk from Deadly Toxicities
Instead of transplanting a heart that has been cooled and stopped, the new technique, at times referred to as “heart in a box”, creates a scenario where the heart that…
Continue Reading
Heart in a Box – a new technique for heart transplantation
For decades exercise has been recommended to improve the quality of life. More recently and perhaps more importantly, exercise has been highly recommended for cancer patients. Most people realize that…
Continue Reading
Analyzing the benefits of Regular exercise for Cancer Patients
Editor's Note: This article was originally published on 3/5/25, and is being republished due to ongoing efforts by Patient Worthy to raise awareness of COPD. A presenter at the COPD…
Continue Reading
The Danger of Misdiagnosing COPD
Saarland University’s medical team, led by Professor Bergita Ganse, has discovered an entirely new approach for monitoring the healing of bone fractures through measuring blood supply to the tissue at…
Continue Reading
A New Method of Monitoring Bone Healing Without X-Ray Radiation